These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17293043)
1. Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Yue W; Kang G; Zhang Y; Qu M; Tang F; Han Y; Ruan Y; Lu T; Zhang J; Zhang D Neurosci Lett; 2007 Apr; 416(1):96-100. PubMed ID: 17293043 [TBL] [Abstract][Full Text] [Related]
2. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Molero P; Ortuño F; Zalacain M; Patiño-García A Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961 [TBL] [Abstract][Full Text] [Related]
3. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Jönsson EG; Saetre P; Vares M; Andreou D; Larsson K; Timm S; Rasmussen HB; Djurovic S; Melle I; Andreassen OA; Agartz I; Werge T; Hall H; Terenius L Neuropsychobiology; 2009; 59(3):142-50. PubMed ID: 19439994 [TBL] [Abstract][Full Text] [Related]
4. Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia. Wirgenes KV; Djurovic S; Agartz I; Jonsson EG; Werge T; Melle I; Andreassen OA Neuropsychobiology; 2009; 60(1):31-6. PubMed ID: 19729970 [TBL] [Abstract][Full Text] [Related]
5. Evidence for transmission disequilibrium at the DAOA gene locus in a schizophrenia family sample. Ma J; Sun J; Zhang H; Zhang R; Kang WH; Gao CG; Liu HS; Ma XH; Min ZX; Zhao WX; Ning QL; Wang SH; Zhang YC; Guo TW; Lu SM Neurosci Lett; 2009 Sep; 462(2):105-8. PubMed ID: 19560517 [TBL] [Abstract][Full Text] [Related]
6. DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes. Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Serretti A Int J Psychiatry Clin Pract; 2011 Nov; 15(4):303-10. PubMed ID: 22122005 [TBL] [Abstract][Full Text] [Related]
7. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Schumacher J; Jamra RA; Freudenberg J; Becker T; Ohlraun S; Otte AC; Tullius M; Kovalenko S; Bogaert AV; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S Mol Psychiatry; 2004 Feb; 9(2):203-7. PubMed ID: 14966479 [TBL] [Abstract][Full Text] [Related]
8. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. Vilella E; Costas J; Sanjuan J; Guitart M; De Diego Y; Carracedo A; Martorell L; Valero J; Labad A; De Frutos R; Nájera C; Moltó MD; Toirac I; Guillamat R; Brunet A; Vallès V; Pérez L; Leon M; de Fonseca FR; Phillips C; Torres M J Psychiatr Res; 2008 Mar; 42(4):278-88. PubMed ID: 17408693 [TBL] [Abstract][Full Text] [Related]
9. Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole. Pae CU; Chiesa A; Serretti A Psychiatry Res; 2010 Jul; 178(2):430-2. PubMed ID: 20471098 [TBL] [Abstract][Full Text] [Related]
11. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients. Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448 [TBL] [Abstract][Full Text] [Related]
12. Testing the antagonistic pleiotropy model of schizophrenia susceptibility by analysis of DAOA, PPP1R1B, and APOL1 genes. Carrera N; Arrojo M; Paz E; Ramos-Ríos R; Agra S; Páramo M; Brenlla J; Costas J Psychiatry Res; 2010 Sep; 179(2):126-9. PubMed ID: 20483474 [TBL] [Abstract][Full Text] [Related]
13. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients. Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; Lee C; Mandelli L; De Ronchi D; Paik IH; Serretti A Neurosci Lett; 2008 Aug; 440(2):150-4. PubMed ID: 18562100 [TBL] [Abstract][Full Text] [Related]
14. Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia. Müller DJ; Zai CC; Shinkai T; Strauss J; Kennedy JL Bipolar Disord; 2011 Mar; 13(2):198-207. PubMed ID: 21443574 [TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia. Cui DH; Jiang KD; Jiang SD; Xu YF; Yao H Mol Psychiatry; 2005 Jul; 10(7):669-77. PubMed ID: 15768050 [TBL] [Abstract][Full Text] [Related]
16. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Stefanis NC; Trikalinos TA; Avramopoulos D; Smyrnis N; Evdokimidis I; Ntzani EE; Ioannidis JP; Stefanis CN Biol Psychiatry; 2007 Oct; 62(7):784-92. PubMed ID: 17336946 [TBL] [Abstract][Full Text] [Related]
17. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia. Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Huang CH; Tsai GE J Clin Psychopharmacol; 2008 Feb; 28(1):64-8. PubMed ID: 18204343 [TBL] [Abstract][Full Text] [Related]
18. The KPNA3 gene may be a susceptibility candidate for schizophrenia. Wei J; Hemmings GP Neurosci Res; 2005 Aug; 52(4):342-6. PubMed ID: 15882913 [TBL] [Abstract][Full Text] [Related]
19. Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients. Wang L; Yu L; He G; Zhang J; Zhang AP; Du J; Tang RQ; Zhao XZ; Ma J; Xuan JK; Xiao Y; Gu NF; Feng GY; Xu MQ; Xing QH; He L Neurosci Lett; 2007 Feb; 414(1):1-4. PubMed ID: 17287080 [TBL] [Abstract][Full Text] [Related]
20. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Corvin A; Donohoe G; Nangle JM; Schwaiger S; Morris D; Gill M Neurosci Lett; 2008 Jan; 431(2):146-9. PubMed ID: 18162312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]